Norethindrone NDC 68180-876

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-876Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0876Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68180-876-73	68180087673	3 BLISTER PACK in 1 CARTON (68180-876-73) / 28 TABLET in 1 BLISTER PACKMarketed from Nov 11, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Norethindrone
Generic name (nonproprietary): norethindrone
Active ingredients: Norethindrone — .35 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091325
Marketing start: Nov 11, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Progesterone Congeners (Chemical structure)
Identifiers: Product ID 68180-876_21d08d75-2957-4610-94c1-76c844ba2f1bSPL ID 21d08d75-2957-4610-94c1-76c844ba2f1bSPL set ID 121fbf86-1d76-4579-be2f-be9a957b23abRxCUI 198042, 748961UNII T18F433X4SUPC 0368180876717
Pharmacologic class: Progestin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468180087673 followed by a unit qualifier and the quantity

Package 68180-0876-73. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 25, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE 1. Indications Progestin-only oral contraceptives are indicated for the prevention of pregnancy. 2. Efficacy If used perfectly, the first-year failure rate for progestin-only oral contraceptives is 0.5%. However, the typical failure rate is estimated to be closer to 5%, due to late or omitted pills. The following table lists the pregnancy rates for users of all major methods of contraception. Table 2. Percentage of Women Experiencing an Unintended Pregnancy During the First Year of Typical Use and the First Year of Perfect Use of Contraception and the Percentage Continuing Use at the End of the First Year. United States. % of Women Experiencing an Unintended Pregnancy w…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091325

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091325
Product	Strength	Form · route	Labeler	Product NDC
Norethindrone	Norethindrone .35 mg/1	TabletOral	Proficient Rx LP	82804-175
Norethindrone	Norethindrone .35 mg/1	TabletOral	A-S Medication Solutions	50090-6161